查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2051065

蛋白質序列分析市場：按技術、產品、應用、最終用戶和地區分類

Protein Sequencing Market, By Technology, By Product, By Application, By End User, By Region
出版日期: | 出版商: Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年，蛋白質定序市場規模將達到26.8億美元，到2033年將達到60.5億美元。預計從2026年到2033年，該市場將以12.3%的複合年成長率成長。

報告範圍 報告詳情
基準年： 2025 2026年市場規模： 26.8億美元
歷史數據時期： 2020年至2024年 預測期： 2026年至2033年
2026年至2033年預測期間的複合年成長率： 12.30% 2033年市場規模預測： 60.5億美元

蛋白質序列測定是生物化學和分子生物學領域中至關重要的技術，用於確定蛋白質中胺基酸的排列順序。這個過程有助於理解蛋白質的結構和功能，而蛋白質對於各種生物過程至關重要。蛋白質序列測定在藥物研發、生物技術和個人化醫療中發揮著舉足輕重的作用。

全球蛋白質序列測定市場正經歷顯著成長，這主要得益於對蛋白質療法的需求不斷成長、蛋白質體學研究的進步以及慢性病盛行率的上升。此外，精準醫療和個人化療法的日益普及也推動了市場成長。例如，致力於加速蛋白質體學發展的Olink Holding AB於2023年9月12日宣布與Eurofins Scientific Group旗下的Eurofins Genomics建立合作夥伴關係。此次合作旨在利用Olink的技術，增強其在研究、公共衛生和受監管的臨床試驗領域的服務能力。

同樣，2022 年 3 月，下一代蛋白質組學解決方案的領導者 Biognosys 宣布推出一套擴展的蛋白質組學平台，為製藥和診斷客戶提供貫穿整個研發流程（從早期藥物發現到臨床應用）的深入生物學見解。

市場動態：

蛋白質定序市場受多種因素驅動。首先，癌症、心血管疾病和神經系統疾病等慢性疾病的日益普遍推動了對基於蛋白質治療方法的需求。蛋白質定序在藥物發現和開發中發揮著至關重要的作用，使研究人員能夠了解疾病機制並開發標靶治療。例如，根據美國疾病管制與預防中心 (CDC) 發布的數據，估計美國超過七分之一的成年人，約 3550 萬人（14%）患有慢性腎臟病(CKD)。 CKD 在 65 歲及以上族群的發生率 (34%) 高於 45-64 歲族群 (12%) 或 18-44 歲族群 (6%)。

此外，蛋白質體學研究的進展為蛋白質定序市場創造了新的機會。質譜和次世代定序等高通量技術的發展徹底改變了蛋白質體學領域，使蛋白質定序更加便捷有效率。

然而，蛋白質定序市場面臨許多挑戰與限制。蛋白質定序設備和試劑的高成本是限制市場成長的主要因素之一。此外，蛋白質結構的複雜性和多樣性也為準確可靠的蛋白質定序帶來了技術挑戰。

儘管如此，蛋白質定序市場仍存在著許多成長機會。特別是，新興國家研發投入的增加預計將為市場相關人員帶來新的發展前景。此外，個人化醫療的興起和標靶治療需求的日益成長，預計也將推動未來對蛋白質定序的需求。

本研究的主要特點：

  • 本研究確定了各個細分市場的潛在商機，並為相關人員提出了一個有吸引力的投資提案矩陣。
  • 本研究深入分析了蛋白質定序市場的市場促進因素、限制因素、機會、市場趨勢以及主要參與者所採取的競爭策略。
  • 該概況根據公司亮點、產品系列、財務表現和策略等參數，概述了全球蛋白質定序市場的主要參與者。
  • 本研究涵蓋的主要公司包括安捷倫科技、賽默飛世爾科技、SGS SA、島津公司、沃特世公司、Bio-Rad Laboratories、布魯克公司、查爾斯河實驗室、Cervita 和 Rapid Novol。
  • 本報告使行銷負責人和經營團隊能夠就未來的產品發布、市場擴張和行銷策略做出明智的決策。
  • 蛋白質定序產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師，都可以從本報告提供的見解中受益。
  • 用於分析全球蛋白質定序市場的策略矩陣有助於相關人員做出明智的決策。

目錄

第1章：研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 加大蛋白質體學研究的投資
    • 抑制因子
    • 蛋白質定序設備和服務高成本
    • 機會
    • 新興市場蘊藏著巨大的成長機會。
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景

第4章 蛋白質序列分析市場：依技術分類，2021-2033年

  • 艾德曼分解
  • 質譜分析
  • 其他

第5章 蛋白質序列分析市場：依產品分類，2021-2033年

  • 裝置
  • 試劑、試劑盒及耗材
  • 軟體和服務

第6章 蛋白質序列分析市場：依應用領域分類，2021-2033年

  • 學術研究
  • 臨床診斷
  • 生物製藥
  • 其他

第7章 蛋白質序列分析市場：依最終用戶分類，2021-2033年

  • 製藥和生物技術公司
  • 學術研究機構
  • 受託研究機構

第8章 蛋白質序列分析市場：依地區分類，2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第9章 競爭情勢

  • Agilent Technologies
  • Thermo Fisher Scientific
  • SGS SA
  • Shimadzu Corp
  • Waters Corp.
  • Bio-Rad Laboratories
  • Bruker Corporation
  • Charles River Laboratories
  • Selvita
  • Rapid Novor Inc.

第10章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI6507

Protein Sequencing Market is estimated to be valued at USD 2.68 Bn in 2026 and is expected to reach USD 6.05 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.3% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 2.68 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 12.30% 2033 Value Projection: USD 6.05 Bn

Protein sequencing is a crucial technique used in the field of biochemistry and molecular biology to determine the order of amino acids in a protein. This process helps in understanding the structure and function of proteins, which are essential in various biological processes. Protein sequencing plays a significant role in pharmaceutical research, biotechnology, and personalized medicine.

The global protein sequencing market has been witnessing significant growth due to the increasing demand for protein-based therapeutics, advancements in proteomics research, and the rising prevalence of chronic diseases. Moreover, the increasing focus on precision medicine and personalized treatments is also driving the market growth. For instance, on September 12 2023, Olink Holding AB, a company dedicated to accelerating proteomics, announced the collaboration with Eurofins Genomics, a division of Eurofins Scientific Group, to bolster its offerings in the fields of research, population health, and regulated clinical trials through the application of Olink technology.

Similarly, in March 2022, Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced the launch of its expanded suite of proteomics platforms that provide pharmaceutical and diagnostics customers with deep biological insights across the entire R&D pipeline, from early stage discovery to clinical settings.

Market Dynamics:

The protein sequencing market is driven by several factors. Firstly, the growing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders, has led to an increased demand for protein-based therapies. Protein sequencing plays a critical role in drug discovery and development, enabling researchers to understand the mechanisms of diseases and develop targeted therapies. For instance, according to data published by Centers for Disease Control and Prevention, more than 1 in 7 US adults-about 35.5 million people, or 14%-are estimated to have Chronic Kidney Disease (CKD). CKD is more common in people aged 65 years or older (34%) than in people aged 45-64 years (12%) or 18-44 years (6%).

Additionally, the advancements in proteomics research have opened up new opportunities for the protein sequencing market. The development of high-throughput technologies, such as mass spectrometry and next-generation sequencing, has revolutionized the field of proteomics, making protein sequencing more accessible and efficient.

However, there are certain challenges and restraints faced by the protein sequencing market. The high cost of protein sequencing instruments and reagents is one of the major hindrances to the market growth. Moreover, the complexity and variability of protein structures pose technical challenges in accurate and reliable protein sequencing.

Nevertheless, the protein sequencing market presents several opportunities for growth. The increasing investment in research and development activities, particularly in emerging economies, is likely to create new prospects for market players. Additionally, the rise in personalized medicine and the need for targeted therapies are expected to drive the demand for protein sequencing in the future.

Key Features of the Study:

  • It elucidates potential revenue opportunities across different market segments and presents attractive investment proposition matrices for stakeholders.
  • The study provides key insights into market drivers, restraints, opportunities, market trends, and competitive strategies adopted by key players in the protein sequencing market.
  • Key players in the global protein sequencing market are profiled based on parameters such as company highlights, product portfolios, financial performance, and strategies.
  • The key companies covered in this study include Agilent Technologies, Thermo Fisher Scientific, SGS S.A., Shimadzu Corp, Waters Corp., Bio-Rad Laboratories, Bruker Corporation, Charles River Laboratories, Selvita, and Rapid Novor Inc.
  • The report enables marketers and management authorities to make informed decisions regarding future product launches, market expansion, and marketing tactics.
  • Various stakeholders in the protein sequencing industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts, can benefit from the insights provided.
  • Strategy matrices used in analyzing the global protein sequencing market will assist stakeholders in making informed decisions.

Protein Sequencing Market Segmentation:

  • By Technology (Revenue, USD Bn, 2021 - 2033)
  • Edman Degradation
  • Mass Spectrometry
  • Others
  • By Product (Revenue, USD Bn, 2021 - 2033)
  • Instruments
  • Reagents, Kits & Consumables
  • Software & Services
  • By Application (Revenue, USD Bn, 2021 - 2033)
  • Academic Research
  • Clinical Diagnosis
  • Biopharmaceuticals
  • Others
  • By End user (Revenue, USD Bn, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Top Companies in Protein Sequencing Market:
  • Agilent Technologies
  • Thermo Fisher Scientific
  • SGS S.A.
  • Shimadzu Corp
  • Waters Corp.
  • Bio-Rad Laboratories
  • Bruker Corporation
  • Charles River Laboratories
  • Selvita
  • Rapid Novor Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Protein Sequencing, By Technology
    • Market Protein Sequencing, By Product
    • Market Protein Sequencing, By Application
    • Market Protein Sequencing, By End user
    • Market Protein Sequencing, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Increasing investments in proteomics research
    • Restraints
    • High costs of protein sequencing instruments and services
    • Opportunities
    • Significant growth opportunities exist in emerging economies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Protein Sequencing Market, By Technology, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Edman Degradation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Mass Spectrometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

5. Protein Sequencing Market, By Product, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
  • Reagents, Kits & Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
  • Software & Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)

6. Protein Sequencing Market, By Application, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Academic Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
  • Clinical Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
  • Biopharmaceuticals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)

7. Protein Sequencing Market, By End user, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Pharmaceutical & Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
  • Contract Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)

8. Protein Sequencing Market, By Region, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023and 2033 (%)
    • Y-o-Y Growth Analysis, For Country 2021 - 2033
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • U.K
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Agilent Technologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • SGS S.A.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Shimadzu Corp
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Waters Corp.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bruker Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Charles River Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Selvita
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Rapid Novor Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us